The number of young people in the US who are prescribed GLP-1 agonist drugs like Wegovy and Ozempic for weight loss and diabetes soared 594.4% in just three years, according to new research.
Comments
( ゚Д゚)
There's nothing here…
The number of young people in the US who are prescribed GLP-1 agonist drugs like Wegovy and Ozempic for weight loss and diabetes soared 594.4% in just three years, according to new research.